ProShares Ultra Nasdaq Biotechnology
BIB
#2831
ETF rank
A$0.15 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$172.39
Share price
-4.80%
Change (1 day)
48.13%
Change (1 year)

Expense ratio and fees for ProShares Ultra Nasdaq Biotechnology (BIB)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 1.17%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%